Skip to content
Lower risk Drug recall · FDA · Published June 29, 2022

Glenmark Telmisartan/Hydrochlorothiazide Tablets Recall: Blister Difficulty Opening

Glenmark recalls specific batches of Telmisartan and Hydrochlorothiazide tablets due to difficult blister opening and tablet breaks. Affected lots have expiration dates through August 2023.

🇺🇸 FDA recall #D-1305-2022DrugGlenmark ›
Take action

Contact the company

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009
✎ GovInfoNow plain-language explainer

Glenmark is recalling certain batches of Telmisartan and Hydrochlorothiazide tablets because the blister packs are hard to open and tablets break during opening. This could lead to improper medication use if the tablets are not taken correctly. Read more at govinfonow.com/recall/34488-glenmark-telmisartan-hydrochlorothiazide-tablets-recall-blister-difficulty-opening.

Source Summary by GovInfoNow · govinfonow.com/recall/34488-glenmark-telmisartan-hydrochlorothiazide-tablets-recall-blister-difficulty-opening · Updated September 23, 2026 · FDA enforcement record: FDA #D-1305-2022

Cite this page

“Glenmark Telmisartan/Hydrochlorothiazide Tablets Recall: Blister Difficulty Opening.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34488-glenmark-telmisartan-hydrochlorothiazide-tablets-recall-blister-difficulty-opening. Based on FDA recall #D-1305-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1305-2022%22&limit=1).

The FDA announced on June 29, 2022, that Glenmark Pharmaceuticals Inc., USA is recalling Telmisartan and Hydrochlorothiazide Tablets USP due to defective containers. The hazard involves difficult-to-open blisters and tablet breakage. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: Glenmark
  • Product: Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only
  • NDC: 68462-842-13
  • Lots: 17210935, 17210936 (Exp 05/2023), 17211206 (Exp 06/2023), 17211652, 17211655, 17211658 (Exp 08/2023)
  • Distribution: nationwide
  • Units: 72,288

The hazard

The recall was initiated due to complaints of difficult-to-open blisters and tablets breaking while opening the blister. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has had 54 other recalls since November 20, 2017. Recent Glenmark recalls include an Azelaic Acid Gel recall on July 23, 2026, for grainy texture risks and an Alyacen Birth Control Tablets recall on May 27, 2026, for impurities risk. Other recent recalls of similar products include Preferred Pharma's Ondansetron ODT recall due to defective seals (November 17, 2025), Harvard Drug Group's Midodrine tablets recall due to defective packaging (February 17, 2026), and an Oxycodone 5mg Tablets recall for weak blister seals (January 14, 2026).

How to tell if you have this one

Check for the product name 'Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only'. Look for specific lot numbers: 17210935, 17210936, 17211206, 17211652, 17211655, or 17211658 with expiration dates through August 2023.

  • Brand
    Glenmark
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    nationwide
  • NDC
    68462-840-13, 68462-841-13, 68462-842-13
Recall numberProduct, codes & lotsQuantity
D-1305-2022Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430, NDC 68462-842-13.; Lots 17210935 & 17210936., Exp Date 05/2023 Lot 17211206, Exp Date 06/2023 Lots 17211652, 17211655 & 17211658, Exp Date 08/202372288 units
D-1306-2022Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc,m USA, Mahwah, NJ 07430, NDC 68462-841-13.; Lots 17210929 & 17210930, Exp Date 05/2023; Lot 17211203, Exp Date 06/2023 & Lots 17211643, 17211646 & 17211649, Exp Date 08/2023—
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the lot number and expiration date on the packaging to determine if it is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Jun 29, 202212. FDA classified it Class II: Aug 5, 202223. Published in FDA’s Enforcement Report: Aug 17, 202234. FDA terminated the recall: Jun 27, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Glenmark recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1305-2022 (June 29, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1305-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA